In today’s briefing:
- Quiddity Leaderboard Singapore’s STI Sep 23: KDCREIT Facing Risk of Deletion
- Esco Lifesciences (1891571D SP) Pre-IPO: A Profitable Revenue Growth Saga
- 10 in 10 with ARA US Hospitality Trust – Recovery On Track
Quiddity Leaderboard Singapore’s STI Sep 23: KDCREIT Facing Risk of Deletion
- In this insight, we take a look at the potential index changes for Singapore’s ST index (“STI”) between now and the September 2023 index review.
- With roughly 4 more months left for the base date, Sembcorp Marine (SMM SP) seems to be an ADD but it is close to the border.
- Since the ranking system used for this index in based on prices as at a single point in time, the rankings could change significantly and our expectations could change too.
Esco Lifesciences (1891571D SP) Pre-IPO: A Profitable Revenue Growth Saga
- Esco Lifesciences Group (1891571D SP), a profitable lifesciences tool provider with a global presence, is looking to raise $300M in its upcoming HK IPO.
- The company clocked revenue of S$117M in 2019, which steadily rose to S$155M in 2020 and S$172M in 2021, representing CAGR of 21%, outpacing lifesciences equipment market growth of 10%.
- In May 2021, Esco raised $200M through series-A fund raising with investors holding nearly 24% of the shares. This puts its valuation at around $840M.
10 in 10 with ARA US Hospitality Trust – Recovery On Track
10 in 10 with ARA US Hospitality Trust – Recovery On Track
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
